Stifel Nicolaus Has Lowered Expectations for Inspire Medical Systems (NYSE:INSP) Stock Price

Inspire Medical Systems (NYSE:INSP) had its price target lowered by Stifel Nicolaus from $200.00 to $190.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. Stifel Nicolaus’ price objective points to a potential upside of 3.15% from the company’s current price.

Several other analysts have also recently issued reports on the company. Robert W. Baird increased their target price on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and increased their price objective for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Wells Fargo & Company boosted their target price on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Truist Financial reiterated a “buy” rating and issued a $240.00 price target (up from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Finally, Piper Sandler restated an “overweight” rating and set a $260.00 price objective (up previously from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $231.64.

Inspire Medical Systems Trading Up 3.7 %

Inspire Medical Systems stock traded up $6.52 during midday trading on Tuesday, hitting $184.20. The stock had a trading volume of 146,653 shares, compared to its average volume of 705,132. Inspire Medical Systems has a 52-week low of $123.00 and a 52-week high of $257.40. The company has a market capitalization of $5.52 billion, a PE ratio of 172.04 and a beta of 1.32. The firm’s fifty day moving average is $188.70 and its two-hundred day moving average is $185.72.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.06 by $0.54. The firm had revenue of $203.20 million for the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The company’s revenue was up 32.6% on a year-over-year basis. During the same period last year, the firm earned ($0.29) EPS. As a group, equities research analysts predict that Inspire Medical Systems will post 1.34 earnings per share for the current fiscal year.

Institutional Trading of Inspire Medical Systems

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP grew its holdings in Inspire Medical Systems by 79.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 109,560 shares of the company’s stock valued at $14,663,000 after purchasing an additional 48,590 shares during the last quarter. Amalgamated Bank grew its stake in shares of Inspire Medical Systems by 4.1% during the second quarter. Amalgamated Bank now owns 2,005 shares of the company’s stock valued at $268,000 after buying an additional 79 shares during the last quarter. Blair William & Co. IL raised its holdings in shares of Inspire Medical Systems by 13.1% in the second quarter. Blair William & Co. IL now owns 7,826 shares of the company’s stock worth $1,047,000 after buying an additional 905 shares during the period. Intech Investment Management LLC lifted its stake in shares of Inspire Medical Systems by 23.3% during the 2nd quarter. Intech Investment Management LLC now owns 12,326 shares of the company’s stock worth $1,650,000 after acquiring an additional 2,328 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its holdings in Inspire Medical Systems by 14.4% during the 2nd quarter. Canada Pension Plan Investment Board now owns 70,500 shares of the company’s stock valued at $9,435,000 after acquiring an additional 8,900 shares during the period. Hedge funds and other institutional investors own 94.91% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.